New brain scan technique aims to catch deadly cancer earlier
NCT ID NCT07415018
Summary
This study aims to see if using a new contrast agent called gadopiclenol during MRI brain scans can help doctors detect leptomeningeal disease (LMD) earlier. LMD is a serious complication where cancer spreads to the lining of the brain and spinal cord. Researchers will test different doses and scan settings in 40 adult cancer patients to find the best way to spot this disease sooner, which could lead to faster treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.